{
    "clinical_study": {
        "@rank": "92504", 
        "arm_group": [
            {
                "arm_group_label": "skin-to-skin", 
                "arm_group_type": "Experimental", 
                "description": "immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours."
            }, 
            {
                "arm_group_label": "standard care", 
                "arm_group_type": "Active Comparator", 
                "description": "after birth the baby is transferred to the neonatal intensive care unit"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to investigate physiological response, social/emotional response and\n      general movements in preterm infants when they are given skin-to-skin contact with the\n      mother (intervention) or standard care (incubator) right after delivery. Preterm infants\n      will be randomized to either intervention or standard care group. Data on body temperature,\n      blood glucose, hart rate, respiration rate and oxygen saturation will be obtained. In\n      addition the infant will be video-recorded during the first 24 hours and at three months of\n      age for analysis of the general movements."
        }, 
        "brief_title": "Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Premature Birth", 
        "condition_browse": {
            "mesh_term": "Premature Birth"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)\n\n        Exclusion Criteria:\n\n          -  Infants who need immediate medical interventions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "32 Weeks", 
            "minimum_age": "28 Weeks"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02024854", 
            "org_study_id": "KC28-32"
        }, 
        "intervention": [
            {
                "arm_group_label": "skin-to-skin", 
                "intervention_name": "skin-to-skin", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "standard care", 
                "intervention_name": "standard care", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Kangaroo-Mother Care Method", 
            "Stress, Physiological"
        ], 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "contact": {
                "last_name": "Laila M Kristoffersen, MSc"
            }, 
            "facility": {
                "address": {
                    "city": "Trondheim", 
                    "country": "Norway"
                }, 
                "name": "NICU St Olavs Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation. A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "laila.kristoffersen@stolav.no", 
            "last_name": "Laila M Kristoffersen, MSc"
        }, 
        "overall_contact_backup": {
            "email": "hakon.bergseng@stolav.no", 
            "last_name": "H\u00e5kon Bergseng, md phd"
        }, 
        "overall_official": {
            "affiliation": "Norwegian University of Science and Technology", 
            "last_name": "H\u00e5kon Bergseng, md phd", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Bayley Scales of Infant Development Third Edition (BSID III)", 
            "measure": "neurodevelopment", 
            "safety_issue": "No", 
            "time_frame": "2 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02024854"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "heart rate", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "measure": "body temperature", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "measure": "respiration frequency", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "measure": "blood glucose", 
                "safety_issue": "No", 
                "time_frame": "4 hours"
            }, 
            {
                "description": "normal/abnormal GM", 
                "measure": "general movements (GM)", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "normal/abnormal", 
                "measure": "general movements", 
                "safety_issue": "No", 
                "time_frame": "12-15 weeks"
            }, 
            {
                "description": "GM optimality score", 
                "measure": "general movements (GM)", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "GM optimality score with subgroups", 
                "measure": "general movements", 
                "safety_issue": "No", 
                "time_frame": "12-15 weeks"
            }
        ], 
        "source": "Norwegian University of Science and Technology", 
        "sponsors": {
            "collaborator": {
                "agency": "St. Olavs Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Norwegian University of Science and Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}